Wednesday, November 11, 2026
22.6 C
Bengaluru

DigiStorm 2018: Intent, Content, Strategy and Skills

[su_dropcap style="flat"]T[/su_dropcap]he pharma industry in India is entering a very interesting variant of the post-digital marketing era. The term “post-digital marketing” is used to depict a state where the lines between physical and digital blur considerably for a customer. However, in the context of pharma, this means a state where the industry has stopped questioning the need for digital and has begun to implement very interesting digital marketing initiatives.

DigiStorm has always been about practising managers sharing their successes and failures and the lessons learned from them, than about theory and concepts.

At DigiStorm 2018 in Bengaluru, the sessions were lined up to explore how pharma is dealing with the post-digital marketing world. DigiStorm has always been about practising managers sharing their successes and failures and the lessons learned from them, than about theory and concepts. Built on a framework of Intent, Content, Strategy and Skills – DigiStorm hosted several CEOs, VPs, BU heads and Marketing/Sales heads who not only shared their experiences on the dais but also comprised the large audience that benefited from the discussions.

Competing Successfully in the Digital Economy

Following on from the highly interactive and eventful CEO Round Table which established the need for top-down engagement and involvement of the C-suite in an organization’s journey into technology and transformation, the second session dealt with VP-Marketing and BU Heads discussing their ‘on-the-ground’ experiences in taking the CEO’s vision forward in terms of execution.

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

Evonile Pharma: The Real Bet Is Not the Acquisition. It is the Field Force.

ChrysCapital’s acquisition of Novartis India and its transformation into...

Closing the Value Gap in Indian Pharma: What Doctors Really Want from Digital Engagement

Indian pharma is investing heavily in digital engagement. But...

Indian Pharma 2026: The Growth Engine Is Changing

The Indian Pharmaceutical Market isn't just growing. Its centre...

Anand Shetty Appointed CEO – Emerging Markets at Cadila Pharmaceuticals

Cadila Pharmaceuticals has appointed Anand Shetty as Chief Executive...

The paradox of the “Pharmacy of the World.” 💊

India has world-scale formulation capability, yet the chemistry beneath...

Topics

Evonile Pharma: The Real Bet Is Not the Acquisition. It is the Field Force.

ChrysCapital’s acquisition of Novartis India and its transformation into...

Indian Pharma 2026: The Growth Engine Is Changing

The Indian Pharmaceutical Market isn't just growing. Its centre...

Anand Shetty Appointed CEO – Emerging Markets at Cadila Pharmaceuticals

Cadila Pharmaceuticals has appointed Anand Shetty as Chief Executive...

The paradox of the “Pharmacy of the World.” 💊

India has world-scale formulation capability, yet the chemistry beneath...

The Innovator’s Gene and the Generic’s Promise

A medicine must first be discovered. It must then...

Private Equity in Indian Healthcare: Who Is Investing Beyond the Metros?

Private capital is transforming India's healthcare landscape. But is...
spot_img

Related Articles

spot_imgspot_img